Funding

Phytolon

Israel · Foodtech · Biotech · Climate tech

Develops natural food colors using precision fermentation technology to replace synthetic dyes

Visit phytolon.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$23.6MColorcon Ventures — Role not disclosedMillennium Foodtech — Role not disclosedNextGen Nutrition (NGN) — Role not disclosedYossi Ackerman — Role not disclosed

Investors

Colorcon VenturesSeries BMillennium FoodtechSeries BNextGen Nutrition (NGN)Series BYossi AckermanSeries B

Coverage

May 26, 2026Phytolon · Series B

Similar companies

Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt
Sourcesphytolon.com ↗